Gallo Guido, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 742
EU - Europa 508
AS - Asia 163
AF - Africa 20
SA - Sud America 2
Totale 1.435
Nazione #
US - Stati Uniti d'America 742
SE - Svezia 147
CN - Cina 99
DE - Germania 90
UA - Ucraina 73
IT - Italia 70
IE - Irlanda 48
IN - India 37
FR - Francia 32
GB - Regno Unito 19
FI - Finlandia 17
CI - Costa d'Avorio 15
TR - Turchia 13
OM - Oman 7
HK - Hong Kong 5
BE - Belgio 3
NL - Olanda 3
BR - Brasile 2
MA - Marocco 2
NG - Nigeria 2
AT - Austria 1
BW - Botswana 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
JP - Giappone 1
RU - Federazione Russa 1
Totale 1.435
Città #
Chandler 199
Jacksonville 59
Dublin 48
New York 44
Ashburn 38
Ann Arbor 34
San Mateo 32
Nanjing 28
Wilmington 23
Cattolica 22
Dearborn 19
Boston 18
Nanchang 17
Abidjan 15
Lawrence 15
Marseille 15
Izmir 13
Beijing 12
Seattle 12
Milan 10
Princeton 10
Redwood City 10
Rome 8
Fairfield 6
Hebei 6
Ariano Irpino 5
Houston 5
Kunming 5
Boardman 4
Hong Kong 4
Jiaxing 4
Lancaster 4
Leawood 4
London 4
Tianjin 4
University Park 4
Bari 3
Detroit 3
Hangzhou 3
Hefei 3
Los Angeles 3
Redmond 3
Simi Valley 3
Zhengzhou 3
Amsterdam 2
Andover 2
Brussels 2
Changsha 2
Costa Mesa 2
Fuzhou 2
Katsina 2
Lviv 2
Mountain View 2
Nimis 2
Orange 2
Oujda 2
Pune 2
Shenyang 2
São Paulo 2
Woodbridge 2
Aprilia 1
Augusta 1
Bremen 1
Budapest 1
Cambridge 1
Central District 1
Changchun 1
Chengdu 1
Civitavecchia 1
Fremont 1
Gaborone 1
Helsinki 1
Indiana 1
Jakarta 1
Laarne 1
Lappeenranta 1
Mazzano Romano 1
Millbury 1
Molfetta 1
Monmouth Junction 1
Mumbai 1
Naples 1
Norwalk 1
Palermo 1
Paris 1
Philadelphia 1
Phoenix 1
San Diego 1
Shanghai 1
Shaoxing 1
St Helens 1
Stockholm 1
Vienna 1
Totale 849
Nome #
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma 91
Targeting the hallmarks of ovarian cancer: The big picture 75
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 73
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 72
Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy 70
Sexual dimorphism in medulloblastoma features 70
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? 69
Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. 67
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer. 66
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 61
The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer 59
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 59
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 58
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 57
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 55
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 52
Hormone receptor expression profile of low-grade serous ovarian cancers 52
The dualistic model of endometrial cancer: The challenge of classifying grade 3 endometrioid carcinoma 51
The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways 50
Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors? 49
Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors? 49
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 46
The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer 28
Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts. 28
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. 25
Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors 22
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 18
Totale 1.472
Categoria #
all - tutte 5.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 0 18 0
2019/2020175 41 2 13 5 7 14 27 0 6 5 39 16
2020/2021137 6 15 5 12 19 10 13 3 18 5 24 7
2021/2022184 15 13 6 11 15 4 2 30 6 10 38 34
2022/2023503 60 84 42 67 30 68 32 33 77 5 2 3
2023/2024182 13 80 1 8 6 50 7 6 1 10 0 0
Totale 1.472